JP2009542205A5 - - Google Patents

Download PDF

Info

Publication number
JP2009542205A5
JP2009542205A5 JP2009518026A JP2009518026A JP2009542205A5 JP 2009542205 A5 JP2009542205 A5 JP 2009542205A5 JP 2009518026 A JP2009518026 A JP 2009518026A JP 2009518026 A JP2009518026 A JP 2009518026A JP 2009542205 A5 JP2009542205 A5 JP 2009542205A5
Authority
JP
Japan
Prior art keywords
epa
culture
microorganism
composition
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009518026A
Other languages
English (en)
Japanese (ja)
Other versions
JP5658876B2 (ja
JP2009542205A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NZ2007/000172 external-priority patent/WO2008004900A1/en
Publication of JP2009542205A publication Critical patent/JP2009542205A/ja
Publication of JP2009542205A5 publication Critical patent/JP2009542205A5/ja
Application granted granted Critical
Publication of JP5658876B2 publication Critical patent/JP5658876B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009518026A 2006-07-05 2007-07-05 大規模従属栄養培養領域にて産生される超高純度ｅｐａと極性脂質 Expired - Fee Related JP5658876B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ548339 2006-07-05
NZ54833906 2006-07-05
PCT/NZ2007/000172 WO2008004900A1 (en) 2006-07-05 2007-07-05 Production of ultrapure epa and polar lipids from largely heterotrophic culture

Publications (3)

Publication Number Publication Date
JP2009542205A JP2009542205A (ja) 2009-12-03
JP2009542205A5 true JP2009542205A5 (https=) 2013-09-12
JP5658876B2 JP5658876B2 (ja) 2015-01-28

Family

ID=38894787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009518026A Expired - Fee Related JP5658876B2 (ja) 2006-07-05 2007-07-05 大規模従属栄養培養領域にて産生される超高純度ｅｐａと極性脂質

Country Status (8)

Country Link
US (3) US8877465B2 (https=)
EP (1) EP2044208A4 (https=)
JP (1) JP5658876B2 (https=)
AU (1) AU2007270135B9 (https=)
CA (1) CA2656311C (https=)
NO (1) NO20090531L (https=)
NZ (1) NZ573719A (https=)
WO (1) WO2008004900A1 (https=)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2397655C (en) 2000-01-19 2012-06-05 Craig M. Ruecker Solventless extraction process
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
EP2334295B1 (en) 2008-09-02 2017-06-28 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
SI2395991T1 (sl) 2009-02-10 2013-12-31 Amarin Pharmaceuticals Ireland Limited Uporaba etil estra eikozapentaenojske kisline za zdravljenje hipertrigliceridemije
SG10201605794PA (en) 2009-04-29 2016-09-29 Amarin Pharmaceuticals Ie Ltd Stable Pharmaceutical Composition And Methods Of Using Same
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
EP3318255B1 (en) * 2009-06-15 2021-03-10 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating stroke in a subject on concomitant statin therapy
US8399226B2 (en) 2009-06-16 2013-03-19 E I Du Pont De Nemours And Company High eicosapentaenoic acid oils from improved optimized strains of Yarrowia lipolytica
CN101613724B (zh) * 2009-07-28 2011-04-06 嘉吉烯王生物工程(湖北)有限公司 重复利用高山被孢霉菌粕制备花生四烯酸的方法
ES2732493T3 (es) * 2009-09-18 2019-11-22 Phycoil Biotechnology Int Inc Fermentación de microalgas usando iluminación controlada
AU2010298222B2 (en) 2009-09-23 2017-01-05 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
EP2519332B1 (en) * 2009-12-30 2014-03-05 BASF Pharma (Callanish) Limited Simulated moving bed chromatographic separation process for the purification of polyunsaturated fatty acids
AU2013204090B2 (en) * 2009-12-30 2015-01-29 Basf Pharma (Callanish) Limited Simulated moving bed chromatographic separation process
US9924733B2 (en) 2010-01-19 2018-03-27 Dsm Ip Assets B.V. Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
WO2011109724A1 (en) * 2010-03-04 2011-09-09 Amarin Pharma, Inc. Compositions and methods for treating and/or preventing cardiovascular disease
EP2576801B1 (en) 2010-06-01 2019-10-02 DSM IP Assets B.V. Extraction of lipid from cells and products therefrom
JP5678180B2 (ja) * 2010-06-09 2015-02-25 フォトンズ コーポレーション リミテッド 高度精製に適した、エイコサペンタエン酸を含む組成物
FR2964667B1 (fr) * 2010-09-15 2014-08-22 Fermentalg Procede de culture d'algues unicellulaires mixotrophes en presence d'un apport lumineux discontinu sous forme de flashs
US20130309719A1 (en) * 2010-10-06 2013-11-21 Photonz Corporation Limited Heterotrophic microbial production of xanthophyll pigments
US10479969B2 (en) 2010-10-11 2019-11-19 Phycoil Biotechnology International. Inc. Utilization of wastewater for microalgal cultivation
NZ744990A (en) * 2010-11-29 2019-10-25 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
CN103327982A (zh) * 2011-02-01 2013-09-25 日本水产株式会社 性功能改善剂
WO2012103685A1 (en) * 2011-02-01 2012-08-09 Nippon Suisan Kaisha, Ltd. Sexual function improving agent
EP2673371A1 (en) * 2011-02-11 2013-12-18 E.I. Du Pont De Nemours And Company An eicosapentaenoic acid concentrate
GB201111595D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Improved process
GB201111594D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New improved process
GB201111591D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Further new process
GB201111589D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New modified process
GB201111601D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New process
AU2012285806B2 (en) * 2011-07-21 2017-09-14 Dsm Ip Assets B.V. Fatty acid compositions
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013070735A1 (en) 2011-11-07 2013-05-16 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
FR2988098A1 (fr) * 2012-03-16 2013-09-20 Fermentalg Production d'acide docosahexaenoique en mode mixotrophe par nitzschia
US9719115B2 (en) * 2012-05-10 2017-08-01 Kyoto University Method for producing oxo fatty acid and rare fatty acid
WO2013192109A1 (en) 2012-06-17 2013-12-27 Matinas Biopharma, Inc. Omega-3 pentaenoic acid compositions and methods of use
NZ727849A (en) 2012-06-29 2018-06-29 Amarin Pharmaceuticals Ie Ltd Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
AU2013354979A1 (en) * 2012-12-06 2015-06-11 Matinas Biopharma, Inc. Administering compositions comprising docosapentaenoic acid
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
AU2013371074B2 (en) * 2012-12-24 2018-07-26 Qualitas Health Inc. Eicosapentaenoic acid (EPA) formulations
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
GB201300354D0 (en) 2013-01-09 2013-02-20 Basf Pharma Callanish Ltd Multi-step separation process
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140275483A1 (en) * 2013-03-15 2014-09-18 Aurora Algae, Inc. Algal oil compositions
WO2014146098A1 (en) * 2013-03-15 2014-09-18 Aurora Algae, Inc. Compositions of crude algal oil
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US9428711B2 (en) 2013-05-07 2016-08-30 Groupe Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US8802880B1 (en) 2013-05-07 2014-08-12 Group Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
JP6563393B2 (ja) 2013-08-01 2019-08-21 フェルマンタル 珪藻バイオマスの生産方法
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
NL2011472C2 (en) * 2013-09-19 2015-03-23 Univ Delft Tech Storage compound production by phototrophic diatoms.
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
EP3118186B1 (fr) 2013-12-11 2022-02-09 Novasep Process Installation chromatographique de production d acides gras polyinsatures
AU2014369040B2 (en) 2013-12-20 2019-12-05 Dsm Ip Assets B.V. Processes for obtaining microbial oil from microbial cells
PL3083546T3 (pl) 2013-12-20 2022-05-16 Dsm Ip Assets B.V. Sposoby wytwarzania oleju mikrobiologicznego z komórek mikrobiologicznych
AR098895A1 (es) 2013-12-20 2016-06-22 Dsm Ip Assets Bv Proceso para obtener aceite microbiano a partir de células microbianas
NZ721413A (en) 2013-12-20 2022-05-27 Dsm Ip Assets Bv Processes for obtaining microbial oil from microbial cells
CN105939710B (zh) 2013-12-20 2020-05-08 帝斯曼知识产权资产管理有限公司 用于从微生物细胞获得微生物油的方法
BR112016015718B1 (pt) 2014-01-07 2021-12-07 Novasep Process Solutions Processo de purificação de aminoácidos aromáticos
JP2015146788A (ja) * 2014-02-07 2015-08-20 三菱マテリアル株式会社 藻類培養方法及び藻類培養装置
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
CN109312370B (zh) * 2016-06-08 2022-06-14 瑞典海藻制造公司 从由工业生物膜处理收获的底栖羽纹硅藻中提取的硅藻壳
CN105912054B (zh) * 2016-06-24 2018-11-20 国网山东省电力公司聊城供电公司 一种油色谱在线装置柜的温控系统及其工作方法与应用
TW201900160A (zh) 2017-05-19 2019-01-01 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法
CN107099379A (zh) * 2017-06-09 2017-08-29 云南中烟工业有限责任公司 一种用于电子烟的津巴布韦烟草净油
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
FR3085962B1 (fr) 2018-09-14 2021-06-18 Fermentalg Procede d'extracton d'une huile riche en pufa
LT3750536T (lt) 2018-09-24 2026-03-25 Amarin Pharmaceuticals Ireland Limited Širdies ir kraujagyslių sistemos reiškinių rizikos subjekto organizme sumažinimo būdai
JP7395144B2 (ja) * 2019-04-05 2023-12-11 三菱重工機械システム株式会社 微細藻培養方法および微細藻培養装置
BR112022009189A2 (pt) 2019-11-12 2022-07-26 Amarin Pharmaceuticals Ie Ltd Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial
WO2021211990A1 (en) * 2020-04-17 2021-10-21 Wake Forest University Lipid compositions and methods of preparation thereof
GB202016236D0 (en) * 2020-10-13 2020-11-25 Givaudan Sa Composition
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1969433U (de) * 1967-04-14 1967-09-28 Bernhard Dipl Ing Winkler Beschilderungselement.
JPS5946225A (ja) * 1982-09-09 1984-03-15 Kogyo Kaihatsu Kenkyusho 抗動脈硬化剤の製造方法
JPS6163624A (ja) * 1984-09-05 1986-04-01 Nisshin Oil Mills Ltd:The エイコサペンタエン酸含量の高い糖脂質の製造法
JPH0297373A (ja) * 1988-09-30 1990-04-09 Koujiyouen:Kk ビールの製造方法
JPH0297393A (ja) 1988-10-03 1990-04-09 Sagami Chem Res Center エイコサペンタエン酸を含むリン脂質組成物の海洋微生物による製造法
JPH02145191A (ja) * 1988-11-29 1990-06-04 Tosoh Corp 海洋性微生物からの高度不飽和脂肪酸の分離方法
US5244921A (en) * 1990-03-21 1993-09-14 Martek Corporation Eicosapentaenoic acids and methods for their production
WO1994024984A2 (en) * 1993-04-30 1994-11-10 Winget Rodner R Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
GB9404483D0 (en) 1994-03-08 1994-04-20 Norsk Hydro As Refining marine oil compositions
DE19629433A1 (de) 1996-07-22 1998-01-29 Hoechst Ag Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier
JP3836231B2 (ja) * 1997-10-17 2006-10-25 日本化学飼料株式会社 ホタテガイ中腸腺から得られる高度不飽和脂肪酸含有油及びその製造方法
AU2004235641B2 (en) * 1999-01-27 2006-09-14 Amarin Neuroscience Limited Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders
CA2273570A1 (en) * 1999-05-31 2000-11-30 Jfs Envirohealth Ltd. Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling
JP4170542B2 (ja) * 1999-11-18 2008-10-22 日油株式会社 高度不飽和脂肪酸誘導体の製造方法及び高純度エイコサペンタエン酸誘導体
CA2397655C (en) * 2000-01-19 2012-06-05 Craig M. Ruecker Solventless extraction process
EP1392623A4 (en) * 2001-05-14 2005-05-04 Martek Biosciences Corp PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS
EP1549753B1 (en) * 2002-10-11 2010-09-08 Nippon Suisan Kaisha, Ltd. Process for producing microbial fat or oil having lowered unsaponifiable matter content
GB0301701D0 (en) 2003-01-24 2003-02-26 Ensay Ltd Psoriasis and Eicosapentaenoic acid
US8557551B2 (en) * 2004-09-10 2013-10-15 Dsm Ip Assets B.V. Compositions and methods for making and modifying oils
JP5491697B2 (ja) * 2004-10-15 2014-05-14 フォトンズ コーポレイション リミテッド 高レベルオメガ−３および低レベル飽和脂肪酸を含む組成物
US20070225370A1 (en) * 2006-03-21 2007-09-27 Joar Opheim Nutritional Compositions and Methods

Similar Documents

Publication Publication Date Title
JP2009542205A5 (https=)
CN104394702B (zh) 用于不断富集由微藻产生的、具有dha乙酯的一种油的方法
US9045784B2 (en) Method for production of euglena containing wax ester at high content, and method for production of wax ester
JP2009149910A5 (https=)
ES2421355T3 (es) Procedimiento para la producción de bioproductos
CN105331572B (zh) 一种发酵高产dha的方法
CN107460216A (zh) 一种利用烟气生产微藻油脂的方法
CN103189520B (zh) 利用生物物质的2-吡咯烷酮的制备方法
JP2018537105A (ja) 高度不飽和脂肪酸、特にオメガ３クラス脂肪酸に富む脂質を含有する原生生物を増殖する方法、及び増殖した原生生物又はその脂質を生産するためのその実施
CN104480152B (zh) 一种提高裂殖壶菌油脂中二十二碳六烯酸含量的方法
CN100503811C (zh) 裂殖壶菌(Schizochytrium)WZU4771及其在制备DHA粉末和油脂中的应用
Gastelum-Franco et al. Preliminary evaluation of the green microalga Dunaliella salina as a potential feedstock for biodiesel: effect of molasses on growth and lipid profile
AU2012284645A1 (en) Method for obtaining an open phototrophic culture with improved storage compound production capacity
CN105713934A (zh) 一种生产微藻油脂的方法
CN101717818B (zh) 一种筛选产多不饱和脂肪酸微生物的方法
CN104894176B (zh) 一种调控裂殖壶菌油脂中dpa/dha比例的调控因子及其调控方法
US20110089370A1 (en) Lipophilic Preparations
CN107460217A (zh) 一种混合培养制备微藻油脂的方法
JP2015505331A (ja) 煙草植物からのバイオ燃料の生産
CN100552029C (zh) 毕赤酵母ω3-脂肪酸脱氢酶启动子序列及其应用
KR101625074B1 (ko) 산화 스트레스를 이용하여 지질함량을 증가시킨 미세조류 및 그의 제조방법
KR20110122426A (ko) Ｔｈｒａｕｓｔｏｃｈｔｒｉｄ계 미세조류의 배양방법
Boopathy et al. Mass cultivation of new algae Tetraselmis straiata BBRR1 under open raceway ponds for biodiesel and biocrude production
KR20260042216A (ko) 높은 epa 함량을 갖는 미생물 오일 및 이의 제조 방법
CN104046568A (zh) 一种富含dha破囊壶菌的培养液及培养方法